Cas:29043-58-1 N-(benzhydrylideneamino)-2-chloroacetamide manufacturer & supplier

We serve Chemical Name:N-(benzhydrylideneamino)-2-chloroacetamide CAS:29043-58-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-(benzhydrylideneamino)-2-chloroacetamide

Chemical Name:N-(benzhydrylideneamino)-2-chloroacetamide
CAS.NO:29043-58-1
Synonyms:Benzophenon-chloracetylhydrazon;HMS2637J15
Molecular Formula:C15H13ClN2O
Molecular Weight:272.73000
HS Code:2928000090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.17g/cm3
Index of Refraction:1.585
PSA:44.95000
Exact Mass:272.07200
LogP:3.63430

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Benzophenon-chloracetylhydrazon chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,HMS2637J15 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzophenon-chloracetylhydrazon Use and application,Benzophenon-chloracetylhydrazon technical grade,usp/ep/jp grade.


Related News: The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. N-(benzhydrylideneamino)-2-chloroacetamide manufacturer With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow. N-(benzhydrylideneamino)-2-chloroacetamide supplier A system that allows Chinese citizens to enter South Korea��s Jeju Island without a visa is to be temporarily suspended. N-(benzhydrylideneamino)-2-chloroacetamide vendor The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. N-(benzhydrylideneamino)-2-chloroacetamide factory A system that allows Chinese citizens to enter South Korea��s Jeju Island without a visa is to be temporarily suspended.